/ /

  • linkedin
  • Increase Font
  • Sharebar

    New Biomarker Could Improve ARDS, AHF Diagnosis


    Soluble suppressor of tumorigenicity-2, an interleukin, is a biomarker of myocardial strain and inflammation that may support prognosis and diagnosis of ARDS.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available